COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 831: Articles 8301-8310  | Next

A quasi-experimental cohort study evaluating a conditional economic incentive on first-dose COVID-19 vaccination rates among older adults in South Africa
Chetty-Makkan, C. M., Thirumurthy, H., Bair, E. F., Bokolo, S., Day, C., Wapenaar, K., Werner, J., Long, L., Maughan-Brown, B., Pascoe, S. J. S., Miot, J., Buttenheim, A.
10.1101/2022.05.06.22274712 — Posted: 2022-05-07
School immunization coverage during the COVID-19 pandemic: A retrospective cohort study
Sell, H., Paudel, Y. R., Voaklander, D., MacDonald, S. E.
10.1101/2022.05.04.22274665 — Posted: 2022-05-07
COVID-19 vaccine effectiveness during a prison outbreak when the Omicron was the dominant circulating variant, Zambia, December 2021
Simwanza, J., Hines, J. Z., Sinyange, D., Sinyange, N., Mulenga, C., Hanyinza, S., Sakubita, P., Langa, N., Nowa, H., Gardner, P., Saasa, N., Chipeta, G., Simpungwe, J., Malambo, W., Hamainza, B., Kapata, N., Kapina, M., Musonda, K., Liwewe, M., Mwale, C., Fwoloshi, S., Mulenga, L. B., Agolory, S., Mukonka, V., Chilengi, R.
10.1101/2022.05.06.22274701 — Posted: 2022-05-07
A statistical definition of epidemic waves
Kriston, L.
10.1101/2022.05.04.22274677 — Posted: 2022-05-07
Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster
Demonbreun, A. R., Sancilio, A., Vaught, L. A., Reiser, N. L., Pesce, L., Sode, E. P., Mustanski, B., D'Aquila, R. T., McNally, E. M., McDade, T. W.
10.1101/2022.05.06.22274719 — Posted: 2022-05-07
Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study
Rennert, L., Ma, Z., McMahan, C., Dean, D.
10.1101/2022.05.06.22274771 — Posted: 2022-05-07
Impact of COVID-19 non-pharmaceutical interventions on pneumococcal carriage prevalence and density in Vietnam
Nation, M. L., Manna, S., Tran, H. P., Nguyen, C. D., Vy, L. T. T., Uyen, D. Y., Phuong, T. L., Dai, V. T. T., Ortika, B. D., Wee-Hee, A. C., Beissbarth, J., Hinds, J., Bright, K., Smith-Vaughan, H., Nguyen, T. V., Mulholland, K., Temple, B., Satzke, C.
10.1101/2022.05.05.22274646 — Posted: 2022-05-07
Longitudinal analysis reveals elevation then sustained higher expression of autoantibodies for six months after SARS-CoV-2 infection
Bhadelia, N., Olson, A., Smith, E., Reifler, K., Cabrejas, J., Ayuso, M. J., Clarke, K., Yuen, R. R., Lin, N., Manickas-Hill, Z., Rifkin, I., Bujor, A. M., Sagar, M., Belkina, A., Snyder-Cappione, J.
10.1101/2022.05.04.22274681 — Posted: 2022-05-07
Deep learning identified genetic variants associated with COVID-19 related mortality
Liu, Z., Dai, W., Wang, S., Yao, Y., Zhang, H.
10.1101/2022.05.05.22274731 — Posted: 2022-05-07
Managing COVID-19 in an Australian designated isolation facility: Implications for current and future healthcare crises
Achat, H. M., Mittal, R., Stubbs, J. M., Gilroy, N., Schindeler, S. K., Shaban, R. Z., Solano, T.
10.1101/2022.05.05.22274702 — Posted: 2022-05-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).